Company Overview
Agilon Health, Inc. operates within the healthcare sector, specifically targeting the Medical Care Facilities industry by delivering essential services to senior populations across the United States. The company utilizes a unique business model that manages the comprehensive healthcare needs of its patient base through a subscription-like per-member per-month framework, primarily engaging primary care physicians embedded within local communities. In terms of scale, the entity holds a market capitalization of $177.23M and reported total annual revenue of $5.93B over the trailing twelve months, supported by an organizational structure comprising 856 employees. These financial dimensions indicate that while the company generates substantial top-line revenue, its relatively modest market cap suggests a valuation that may reflect market skepticism regarding its profitability or specific operational challenges inherent to its service delivery model.
Financial Health
The financial performance of agilon health, inc. is characterized by significant negative profitability metrics, with trailing twelve-month revenue of $5.93B, net income of $-405,347,008, and EBITDA of $-406,182,016. The substantial gap between the $5.93B revenue figure and the negative net income reveals a cost structure where expenses, including cost of goods sold and operational expenditures, vastly exceed total revenue, resulting in a gross margin of -2.7%, an operating margin of -10.0%, and a profit margin of -6.6%. These negative margin levels indicate that for every dollar of revenue generated, the company loses money after accounting for direct costs, operating overhead, and all other expenses, signaling a current inability to convert sales into profit. Regarding cash flow dynamics, the company reports free cash flow of $-81,226,128, which implies that capital expenditures and operating cash outflows are consuming cash reserves rather than generating liquidity. On the balance sheet, agilon health, inc. holds $285.14M in cash against $36.81M in debt, resulting in a debt-to-equity ratio of 29.05, which suggests a leveraged position despite the absolute dollar amount of debt being low relative to cash holdings. Liquidity is further assessed by a current ratio of 1.02, indicating that current assets barely cover current liabilities, which presents a tight margin for short-term financial obligations. Finally, the return metrics show a return on equity of -135.6% and a return on assets of -17.5%, revealing that management effectiveness in generating returns for shareholders and utilizing asset base has been severely negative during the reporting period.
Valuation Assessment
The valuation multiples for agilon health, inc. present a complex picture given its lack of positive earnings, with a trailing P/E ratio of N/A and a forward P/E of -2.37. The absence of a trailing P/E ratio combined with a negative forward P/E implies that the market cannot value the stock based on historical or near-term earnings power, often leading analysts to rely on alternative metrics to assess worth. The price-to-book ratio stands at 1.40, indicating that the market values the company at 40% above its book value, which may suggest a premium for its platform technology or growth potential despite current losses. Alternative valuation metrics such as the price-to-sales ratio of 0.03 and an EV/EBITDA of 0.17 suggest that the stock is priced very low relative to its massive revenue base, potentially reflecting high perceived risk or a lack of consensus on future earnings realization. Price action over the last year shows a 52-week high of $6.08 and a 52-week low of $0.34, and without a specific current price listed in the provided facts, the exact percentage distance from these bounds cannot be calculated, though the wide range indicates significant price volatility. The stock exhibits a beta of 0.11, which means its price volatility is significantly lower than the broader market, suggesting that the stock price moves independently of general market fluctuations, likely driven by specific company news or sector developments rather than macroeconomic trends.
Growth & Income
The company demonstrates a revenue growth rate of 3.1% year-over-year, while earnings growth is listed as N/A due to the absence of positive earnings in the prior period. Because earnings are negative, there is no meaningful comparison between the speed of earnings growth and revenue growth, but the positive revenue expansion indicates that the company is successfully acquiring new members or retaining existing ones under its subscription model. As a non-dividend payer, the company does not distribute a dividend yield, maintaining a payout ratio of 0.0%, which implies that any generated cash or retained earnings are being reinvested into operations, technology, or expansion rather than being distributed to shareholders. This reinvestment strategy is typical for growth-stage healthcare companies that prioritize scaling their per-member per-month platform over returning capital to investors. Overall, the growth and income profile reflects a business that is expanding its top line but remains in a phase of heavy investment that suppresses profitability and precludes dividend payments, relying on future operational improvements to eventually generate positive cash flows and earnings.